Lara Dunn
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Head and Neck Surgical Oncology, Cancer Immunotherapy and Biomarkers, Salivary Gland Tumors Diagnosis and Treatment
Most-Cited Works
- → PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma(2018)1,358 cited
- → Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial(2021)589 cited
- → Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma(2020)385 cited
- → Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial(2020)267 cited
- → Scientific Collaboration Results in Higher Citation Rates of Published Articles(2006)242 cited
- → Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques(2017)240 cited
- → Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers(2018)237 cited
- → Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma(2019)231 cited
- → Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing(2020)172 cited
- → A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma(2016)117 cited